6198-57-8

Basic information

• Product Name: (6R,9S)-6-methyl-10-methylidenedodecahydro-5H-8a,11-methano-6,13b-propanocyclohepta[h][1,3]oxazolo[2,3-a]isoquinolin-9(13cH)-ol hydrochloride (1:1)
• CAS NO: 6198-57-8
• Molecular Formula: C₂₂H₃₄ClNO₂
• Molecular Weight: 379.9639
• Mol File: 6198-57-8.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 482.2°C at 760 mmHg
• Flash Point: 245.4°C
• Vapor Pressure: 2.55E-11mmHg at 25°C
• CAS DataBase Reference: (6R,9S)-6-methyl-10-methylidenedodecahydro-5H-8a,11-methano-6,13b-propanocyclohepta[h][1,3]oxazolo[2,3-a]isoquinolin-9(13cH)-ol hydrochloride (1:1)(CAS DataBase Reference)
• NIST Chemistry Reference: (6R,9S)-6-methyl-10-methylidenedodecahydro-5H-8a,11-methano-6,13b-propanocyclohepta[h][1,3]oxazolo[2,3-a]isoquinolin-9(13cH)-ol hydrochloride (1:1)(6198-57-8)
• EPA Substance Registry System: (6R,9S)-6-methyl-10-methylidenedodecahydro-5H-8a,11-methano-6,13b-propanocyclohepta[h][1,3]oxazolo[2,3-a]isoquinolin-9(13cH)-ol hydrochloride (1:1)(6198-57-8)

Safety Data

• Hazardous Substances Data: 6198-57-8(Hazardous Substances Data)

Usage

Description

(6R,9S)-6-methyl-10-methylidenedodecahydro-5H-8a,11-methano-6,13b-propanocyclohepta[h][1,3]oxazolo[2,3-a]isoquinolin-9(13cH)-ol hydrochloride (1:1), also known as talsaclidine hydrochloride, is a complex organic compound with potential therapeutic effects on neurological and psychiatric disorders. It functions as a selective M1/Muscarinic receptor agonist, which allows it to modulate the release of neurotransmitters such as dopamine, acetylcholine, and glutamate. Its unique molecular structure and mechanism of action make it a promising candidate for the treatment of conditions like Alzheimer's disease, schizophrenia, and Parkinson's disease. Further research and clinical trials are necessary to fully comprehend its therapeutic potential and safety profile.

Uses

Used in Pharmaceutical Industry:
Talsaclidine hydrochloride is used as a therapeutic agent for the treatment of neurological and psychiatric disorders. Its agonistic action on the M1/Muscarinic receptor modulates the release of neurotransmitters, which can potentially alleviate the symptoms of conditions such as Alzheimer's disease, schizophrenia, and Parkinson's disease.
Used in Research and Development:
In the field of medical research, talsaclidine hydrochloride serves as a valuable compound for studying the role of M1/Muscarinic receptors in neurological and psychiatric disorders. It can be utilized in preclinical trials and laboratory experiments to better understand the underlying mechanisms of these conditions and to develop new treatment strategies.
Used in Clinical Trials:
Talsaclidine hydrochloride is employed in clinical trials to evaluate its efficacy and safety in treating neurological and psychiatric disorders. These trials are crucial for determining the optimal dosage, potential side effects, and overall therapeutic potential of the compound before it can be approved for widespread use in medical treatments.